172@29@16@59!~!172@29@0@53!~!|commonstore|commonfiles|moneycontrol_header.php?cid=0&s_cid=0&radar_off=0&is_revamped_header=0&is_responsive=1&sec=PNC_ANNOUNCEMENT&priceinter=1&frommc=1!~!www|moneycontrol|com!~!|commonstore|commonfiles|moneycontrol_header.php!~!is_mobile=false
Moneycontrol
SENSEX NIFTY
you are here:

Venus Remedies Ltd.

BSE Live

Sep 29, 16:00
132.00 -2.60 (-1.93%)
Volume
AVERAGE VOLUME
5-Day
8,052
10-Day
9,678
30-Day
10,730
5,615
  • Prev. Close

    134.60

  • Open Price

    133.65

  • Bid Price (Qty.)

    129.10 (100)

  • Offer Price (Qty.)

    132.00 (15)

NSE Live

Sep 29, 15:44
130.00 -4.65 (-3.45%)
Volume
AVERAGE VOLUME
5-Day
37,579
10-Day
53,806
30-Day
49,604
22,153
  • Prev. Close

    134.65

  • Open Price

    136.65

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

ANNOUNCEMENTS ON Venus Remedies

  • Sep 24, 2020 14:24 Source: NSE

    Venus Remedies Limited

    The Exchange has sought clarification from Venus Remedies Limited for the quarter ended 30-Jun-2020 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: 1. Machine Readable Form / Legible copy of Financial Results not submitted.The response of the Company is awaited.

  • Sep 24, 2020 14:01 Source: NSE

    Venus Remedies Limited

    The Exchange has sought clarification from Venus Remedies Limited for the quarter ended 30-Jun-2020 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: 1. Machine Readable Form / Legible copy of Financial Results not submitted.The response of the Company is awaited.

  • Sep 19, 2020 16:35 Source: BSE

    Venus Remedies - Announcement under Regulation 30 (LODR)-Newspaper Publication

    newspaper publication of Unaudited Financial Results for the quarter ended on 30.06.2020

  • Sep 19, 2020 13:48 Source: BSE

    Venus Remedies - Disclosure Of Related Party Transaction Pursuant To Regulation 23(9) Of The SEBI ( Listing Obligations & Disclosures Requirements) Regulations, 2015

    Pursuant to regulation 23(9) of the SEBI (Listing Obligations & Disclosures Requirements) Regulations, 2015, kindly find enclosed herewith a disclosure on related party transaction on Consolidated basis, as per the format specified in Accounting Standards for the year ended on 31st March 2020.

  • Sep 15, 2020 20:34 Source: BSE

    Venus Remedies - UNAUDITED FINANCIAL RESULTS

    UFR AS ON 30.06.2020

  • Sep 15, 2020 20:10 Source: BSE

    Venus Remedies - OUTCOME OF BOARD MEETING

    This has reference to the meeting of Board of Directors held on 15th September 2020 inter alia considered and approved the Unaudited Financial Results for the quarter ended on 30.06.2020 along with Limited Review report.

  • Sep 05, 2020 17:29 Source: BSE

    Venus Remedies - Board Meeting Intimation for Notice Of Board Meeting

    VENUS REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/09/2020 ,inter alia, to consider and approve This is to inform you that the meeting of Board of Directors is scheduled to be held on Tuesday, 15th September 2020 to inter alia consider and approve as below: 1. Un-audited Financial Results for the quarter ended on 30.06.2020 2. Any other item with the permission of chair. Further, as already informed, the trading window would remain closed till 48 hours from the publication of financial results for designated persons and their immediate relatives, in view of the aforesaid Board meeting.

  • Sep 05, 2020 17:18 Source: BSE

    Venus Remedies - Intimation Regarding One-Time Settlement Pursuant To Regulation 30 Of The SEBI (LODR) Regulations, 2015

    Pursuant to regulation 30 of SEBI (Listing Obligation and Disclosures Requirements) Regulations, 2015, this is to inform you that in line with the company''s ongoing discussion with consortium lenders for settlement of outstanding dues of NPA loan accounts, it has entered into a one-time settlement of loan accounts with Corporation Bank (Now Union Bank of India), IDBI Bank, Bank of Baroda, HDFC Bank Ltd. and Export Import Bank of India, as per the respective terms and conditions of the said banks. Reason for the settlement: The Company''''s loan accounts were classified as NPA with the above said banks and the settlement was carried out to provide long-term sustainability to the Company''s operations. This is for your information and record please.

  • Aug 21, 2020 21:44 Source: BSE

    Venus Remedies - Financial Results For The Quarter And Year Ended On 31St March 2020.

    Financial Results for the quarter and year ended on 31st March 2020.

  • Aug 21, 2020 21:41 Source: BSE

    Venus Remedies - Outcome Of Board Meeting Dated 21.08.2020

    Outcome as per enclosed file.

CORPORATE ANNOUNCEMENTS

BOARD MEETING

Meeting Date : Sep 15, 2020
Remark : Quarterly Results